These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10194596)

  • 21. Aqueous solubility of diclofenac diethylamine in the presence of pharmaceutical additives: a comparative study with diclofenac sodium.
    Khalil E; Najjar S; Sallam A
    Drug Dev Ind Pharm; 2000 Apr; 26(4):375-81. PubMed ID: 10769778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate.
    Greco K; Bogner R
    AAPS PharmSciTech; 2011 Sep; 12(3):909-16. PubMed ID: 21732157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
    Billa N; Yuen KH; Peh KK
    Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.
    Bodmeier R; Guo X; Sarabia RE; Skultety PF
    Pharm Res; 1996 Jan; 13(1):52-6. PubMed ID: 8668678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double controlled release of highly insoluble cilostazol using surfactant-driven pH dependent and pH-independent polymeric blends and in vivo bioavailability in beagle dogs.
    Nam KY; Cho SM; Choi YW; Park C; Meghani NM; Park JB; Lee BJ
    Int J Pharm; 2019 Mar; 558():284-290. PubMed ID: 30641181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of process variables of preparation of oxycellulose beads on their dissolution profile.
    Bajerová M; Muselík J; Gajdziok J; Masteiková R; Dvorácková K
    Acta Pol Pharm; 2013; 70(2):271-81. PubMed ID: 23614283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative treatment of diclofenac via ferrate(VI) in aqueous media: effect of surfactant additives.
    Wang Y; Ni T; Yuan J; Wang C; Liu G
    Water Sci Technol; 2017 Mar; 75(5-6):1342-1350. PubMed ID: 28333050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of surfactants on the solubility and intrinsic dissolution rate of sparfloxacin.
    Mbah CJ; Ozuo CO
    Pharmazie; 2011 Mar; 66(3):192-4. PubMed ID: 21553649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein partitioning in weakly charged polymer-surfactant aqueous two-phase systems.
    Sivars U; Bergfeldt K; Piculell L; Tjerneld F
    J Chromatogr B Biomed Appl; 1996 May; 680(1-2):43-53. PubMed ID: 8798880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac.
    O'Connor KM; Corrigan OI
    Int J Pharm; 2001 Jul; 222(2):281-93. PubMed ID: 11427358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubilization of flurbiprofen within non-ionic Tween 20 surfactant micelles: a 19F and 1H NMR study.
    Saveyn P; Cocquyt E; Zhu W; Sinnaeve D; Haustraete K; Martins JC; Van der Meeren P
    Phys Chem Chem Phys; 2009 Jul; 11(26):5462-8. PubMed ID: 19551216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug.
    Djordjevic L; Primorac M; Stupar M; Krajisnik D
    Int J Pharm; 2004 Mar; 271(1-2):11-9. PubMed ID: 15129969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a pH-responsive imprinted polymer for diclofenac and study of its binding properties in organic and aqueous media.
    Mohajeri SA; Malaekeh-Nikouei B; Sadegh H
    Drug Dev Ind Pharm; 2012 May; 38(5):616-22. PubMed ID: 21978326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatographic behaviour in reversed-phase high-performance liquid chromatography with micellar and submicellar mobile phases: effects of the organic modifier.
    Fischer J; Jandera P
    J Chromatogr B Biomed Appl; 1996 May; 681(1):3-19. PubMed ID: 8798907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new controlled-release liquid delivery system based on diclofenac potassium and low molecular weight chitosan complex solubilized in polysorbates.
    Athamneh NA; Tashtoush BM; Qandil AM; Al-Tanni BM; Obaidat AA; Al-Jbour ND; Qinna NA; Al-Sou'od K; Al-Remawi MM; Badwan AA
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1217-29. PubMed ID: 22873834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
    Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
    Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of surfactants on the crystal growth of amorphous celecoxib.
    Mosquera-Giraldo LI; Trasi NS; Taylor LS
    Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratin-rhamnolipids and keratin-sodium dodecyl sulfate interactions at the air/water interface.
    Ozdemir G; Sezgin OE
    Colloids Surf B Biointerfaces; 2006 Sep; 52(1):1-7. PubMed ID: 16837174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.